Delivery Order SPE2DB22D1041-SPE2DB25FTYL2

Award Date 11/19/24
Potential Completion Date 11/20/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTYL2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,485,984 units of the Advair HFA 230-21 MCG Inhaler medical product. The contract has a firm fixed price of $5,123.72 and runs through November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary procurement mechanism for the DLA to acquire a wide range of pharmaceutical and medical supplies, including specialty medications, generic drugs, vaccines, and medical devices, in support of military healthcare programs. This particular delivery order does not have a set-aside designation, indicating open competition.

Generated 2/18/25, 1:50 PM